Laboratory Equipment
Laboratory equipment for clinical labs and pathology groups includes a wide range of devices and instruments, some of which are familiar to the general public and some of which are highly specialized to clinical lab work.
Laboratory equipment is generally used to either perform an experiment or to take measurements and gather data. Larger or more sophisticated equipment is generally called a scientific instrument.
Such equipment includes test tubes, Folin-Wu tubes for blood glucose determination, petri dishes, beakers, flasks, Pasteur pipettes, glass slides, syringes and needles, autoclave, disposable gloves, tourniquets, microscopes, Bunsen burners, ultracentrifuge, electrophoresis apparatus, chromatography system, hematology analyzer, chemistry analyzer, semiauto analyzer, reflotron, setup for radioimmunoassay, setup for enzyme linked immunosorbant assay, (ELISA, colorimeter, burette, induction coils, cathode ray oscilloscope, recording kymograph and surface plasmon resonance equipment and various reagents.)
Other laboratory equipment might include a skin analyzer, oxygen analyzer, flouresence microscope, spectrum analyzer, and a digital pathology scanner, among many others.
At the same time, technology is advancing to the point where the capabilities of an entire laboratory can now be contained in relatively small devices. One relatively new device the size of a cola can is paired with a smartphone and can diagnose diseases like a clinical laboratory.
Another such device, marketed largely to developing countries that lack a well-developed network of clinical laboratories, is a credit-card-size anthrax detector that also works like a portable medical laboratory in the field.
In addition, research organizations, including one in the United States, one in New Zealand, and two in the U.K., have unveiled several devices that will analyze DNA in the field. Again, this line of research is of particular interest in developing countries where resources such as electricity for refrigeration are scarce. Some of the DNA testing devices will produce results in minutes to hours, eliminating the need to return to a clinical laboratory to analyze samples.
Ranging in size from little more than a pack of gum to about the size of a large brick, these devices for DNA analysis have the potential to serve as mobile medical laboratories for pathologists in the field.
QuidelOrtho Earns $3.3 Billion in First Year as Combined Firm
IN OUR FEBRUARY 13, 2023, ISSUE OF THE DARK REPORT, we analyzed the 2022 full-year and Q4 earnings of major IVD companies. At the time our prior issue went to press, QuidelOrtho had not yet reported its year-end results. …
Pandemic Helped Lab with Hospital Leaders
CEO SUMMARY: Growth at Atrium Health during the COVID-19 pandemic elevated its clinical laboratory’s profile with medical leaders and health system administrators. What followed was a new spirit of collaboration that led to lab involvement in cost savings efforts, such as improved…
Public IVD Companies Report Q4, Full-Year 2022 Earnings
YEAR-END AND Q4 EARNINGS REPORTS FROM MAJOR IN VITRO DIAGNOSTICS (IVD) COMPANIES pointed to a welcome sign of core diagnostic business rebounding. That’s the good news for IVD firms. The bad news? All of the SARS-CoV-2 testing revenue that th…
Siemens Healthineers Plans to Streamline Product Offerings
DURING A 15-MONTH STRETCH FROM 2006-2007, Siemens Healthineers spent $14 billion to acquire three competing companies and their various technologies. Today, Siemens is preparing to sunset as many as half of its legacy instruments and assays, whic…
Babson Diagnostics’ Hybrid Model Combines Quality, Convenience
CEO SUMMARY: Responding to its own data about consumer preferences, healthcare technology company Babson Diagnostics is pursuing a new hybrid model for blood draws that it believes brings together the best of clinical laboratories and retail pharmacies. Laboratory managers and patho…
News and Insights from AACC Meeting in Chicago
CEO SUMMARY: There was plenty of positive energy last month when the 72nd Annual Scientific Meeting and Exhibition of the American Association of Clinical Chemistry (AACC) took place in Chicago. Attendees seemed pleased to be gathering and networking in person. However, there was re…
Anticipating Change in COVID-19 Test Volume
CEO SUMMARY: New and more easily transmitted variants of SARS-CoV-2 are causing surges…
Labs Use IoT Tools for Specimen Logistics
CEO SUMMARY: Internet of Things (Io…
Post-COVID: Repurposing Excess PCR Instruments
CEO SUMMARY: Currently, there are hospital, health system, and independent clinical laboratories that have between two and five different PCR testing platforms. These analyzers were acquired during the pandemic as one way to increase the daily number of SARS-CoV-2 their labs could p…
Labcorp Now Using AI for Operations, Patient Care
CEO SUMMARY: In recent years, Labcorp invested significant sums to use artificial intelligence and machine learning technologies—often integrated with robotic systems—to improve work processes and gain real-time insights from vast amounts of data. In this exclusive interview, La…
CURRENT ISSUE
Volume XXXI, No. 5 – April 8, 2024
The fragmentation of consumer markets is reflected in clinical lab services, and The Dark Report examines this trend and how it will impact labs in the coming years. Also, The Dark Report notes that the FDA has issued a controversial memo to reclassify many high-risk IVD assays.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.